Rallybio Corp
Current role
RLYB
Mohammad Hirmand, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mohammad Hirmand, M.D.
Rallybio Corp reported in an 8-K filed June 1, 2026 that Mohammad Hirmand, M.D. was appointed Chief Medical Officer of the combined company.
“Mohammad Hirmand, M.D., the Chief Medical Officer of Avenzo, will serve as the Chief Medical Officer of the combined company; and”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Rallybio Corp (RLYB)
SEC 8-K
Current2026-06-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Rallybio Corp
Other people whose current roles at this company are on record from its filings.
- Athena Countouriotis, M.D. CEO
- Stephen Uden CEO, COO, Board Member
- Stephen Uden, M.D. CEO, Board Member
- Martin Mackay, Ph.D. Chairman
- Jonathan I. Lieber CFO
- Scott Lipman, M.B.A. CFO
- Brian Sun, J.D. General Counsel
- Christine A. Nash Board Member
- Helen M. Boudreau Board Member
- Hui Liu Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.